These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9498941)

  • 61. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
    Horiguchi T; Hayashi N; Ohira D; Torigoe H; Ito T; Hirose M; Sasaki Y; Shiga M; Miyazaki J; Kondo R; Tachikawa S
    J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
    Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
    Nightingale JA; Rogers DF; Barnes PJ
    Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC.
    Vastagh E; Kuna P; Calistruc P; Bogdan MA;
    Respir Med; 2003 Nov; 97 Suppl D():S20-8. PubMed ID: 14753248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED; Kornmann O; Schmidt P; Pivovarova A; Engel M; Fabbri LM
    J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of repeat action albuterol sulfate (Proventil Repetabs) in nocturnal symptoms of asthma.
    Storms WW; Nathan RA; Bodman SF; Morris RJ; Selner JC; Greenstein SM; Zwillich CW
    J Asthma; 1992; 29(3):209-16. PubMed ID: 1351053
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo.
    Langley SJ; Masterson CM; Batty EP; Woodcock A
    Eur Respir J; 1998 May; 11(5):1081-5. PubMed ID: 9648959
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of inhaled albuterol in moderate to severe asthma.
    Apter AJ; Reisine ST; Willard A; Clive J; Wells M; Metersky M; McNally D; ZuWallack RL
    J Allergy Clin Immunol; 1996 Aug; 98(2):295-301. PubMed ID: 8757206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
    Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L
    Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL; Noonan MJ; Weinstein SF; Chervinsky P; Scott CA; Herje NE; Wu W; Crim C
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
    BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma.
    Leblanc P; Knight A; Kreisman H; Borkhoff CM; Johnston PR
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):324-8. PubMed ID: 8756801
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.